---
title: Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction
date: '2023-08-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37634190/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20230828184236&v=2.17.9.post6+86293ac
source: N Engl J Med
description: 'CONCLUSIONS: Among patients in hemodynamically stable condition with
  STEMI and multivessel coronary artery disease, immediate multivessel PCI was noninferior
  to staged multivessel PCI with respect to the risk of death from any cause, nonfatal
  myocardial infarction, stroke, unplanned ischemia-driven revascularization, or hospitalization
  for heart failure at 1 year. (Supported by Boston Scientific; MULTISTARS AMI ClinicalTrials.gov
  number, ...'
disable_comments: true
---
CONCLUSIONS: Among patients in hemodynamically stable condition with STEMI and multivessel coronary artery disease, immediate multivessel PCI was noninferior to staged multivessel PCI with respect to the risk of death from any cause, nonfatal myocardial infarction, stroke, unplanned ischemia-driven revascularization, or hospitalization for heart failure at 1 year. (Supported by Boston Scientific; MULTISTARS AMI ClinicalTrials.gov number, ...